License agreement to enhance Nippon Gene’s CRISPR/Cas9 research reagents offering Dublin, Ireland and Tokyo, Japan, 01 July 2021: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents […]
Shoreline Biome’s microbiome products now available in the Nordics FARMINGTON, Conn.— Shoreline Biome, a leading microbiome company that develops complete solutions for characterizing microbiome populations down to the strain level, has entered into a partnership with AH diagnostics A/S for product distribution. Shoreline Biome’s complete suite of products for use on the industry leading next […]
Global strategic alliance to leverage Sysmex’s Plasma-Safe-SeqS technology QIAGEN will use ultra-sensitive liquid biopsy applications in oncology Alliance boosts QIAGEN’s co-development of companion diagnostics with drug makers QIAGEN expects significant benefits for pharma companies and cancer patients worldwide Hilden, Germany, Germantown, Maryland, and Kobe, Japan – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced […]
Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, launched a new application suite for the characterization of nanoparticles on Stunner today. Stunner is already the go-to solution for AAV titer and empty/full ratio measurements, and now it takes on payload quant […]
Tromsø, Norway — ArcticZymes Technologies ASA (OSE: AZT) announces the launch of the second generation of its SAN HQ enzyme ArcticZymes Technologies´ Salt Active Nuclease High Quality (SAN HQ) enzyme has achieved significant penetration in the viral vector manufacturing space in the last 5 years. Viral vectors are used in therapeutic applications such as vaccines […]
Pleasanton, Calif.—Apton Biosystems, Inc., a developer of Super-Res sequencing and single-molecule detection systems for large-scale clinical applications, such as early cancer detection and population sequencing, today announced the close of a $24 million Series-A financing. The financing was led by Kern Capital with participation by new and existing investors including Casdin Capital and Khosla Ventures. […]
— Accelerates Conversion from Microarray to Genotyping by Sequencing– — Expands NGS Capabilities into New Markets — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the acquisition of iGenomX, a company offering multiplex library […]
HELSINKI, Finland — Euformatics, a bioinformatics software company providing world-leading NGS interpretation and quality control tools has signed a distribution agreement with INSVAST, a company specialising in delivering bioinformatics solutions to Chinese NGS laboratories. The agreement covers the full omnomics Suite of products from Euformatics and provides INSVAST with a full end-to-end offering to their customers […]
Porvair Sciences has further expanded its range of high-performance microplate products for SARS-CoV-2 nucleic acid purification. The new KF deep well plate and tip comb plate combo are specifically designed to enhance the performance and productivity of the market-leading Thermo Scientific™ KingFisher™ range of nucleic acid purification systems. Krzysztof Kielmann, microplates product manager at Porvair Sciences commented “The Kingfisher Flex […]
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the close of a $276 million Series C financing. New investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price joined existing investors Fidelity Management & Research Company, Foresite Capital, JS Capital Management LLC, RA Capital Advisors, and Venrock. With this latest investment, Element Biosciences […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
